Regulation A · Tier 1 · CBDL
CBD Life Sciences Inc.
CBD Life Sciences Inc. (CBDL) filed a Tier 1 Regulation A offering statement (Form 1-A) on Aug 18, 2022 for up to $9.5M at $0.0003 per security. The SEC qualified the offering on Aug 26, 2022.
- Status
- Qualified
- Tier
- Tier 1
- Offering size
- $9.5M
- Offer price
- $0.0003
- Security type
- Equity (common or preferred stock)
- Filed
- Aug 18, 2022
- Qualified
- Aug 26, 2022
- Ticker
- CBDL
- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- State
- AZ
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Aug 18, 2022
- Exit report (Form 1-Z)
- All filings on EDGAR CIK 1776073
Other qualified Biotech & pharma Reg A offerings
- MXY Holdings Inc.Oct 21, 2022 · $75M
- Maverick Lifestyle Inc.Sep 6, 2022 · $25M
- Puraverde Inc.Aug 11, 2022 · $50M
- Oncolyze, Inc.Aug 4, 2022 · $15.3M
- Kurve Therapeutics, Inc.Aug 3, 2022 · $50M
- Aeris Biotechnologies, Inc.Jul 26, 2022 · $15M